What is the significance of finding endometrial cells on a Pap (Papanicolaou) smear?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Endometrial Cells on Pap Smear

The significance of endometrial cells on Pap smear depends primarily on menopausal status, with postmenopausal women requiring endometrial assessment regardless of symptoms, while premenopausal women generally need no further evaluation unless symptomatic.

Clinical Significance Based on Menopausal Status

Premenopausal Women

  • For asymptomatic premenopausal women with benign endometrial cells, endometrial stromal cells, or histiocytes on Pap smear, no further evaluation is recommended as these findings are rarely associated with significant pathology 1
  • Benign endometrial cells are a normal finding during the proliferative phase of the menstrual cycle in premenopausal women 1

Postmenopausal Women

  • Approximately 0.5-1.8% of cervical cytology specimens from women 40 years and older will contain endometrial cells 1, 2
  • Benign-appearing endometrial cells in postmenopausal women are associated with significant endometrial pathology in approximately 7% of cases 1, 2
  • Studies have found endometrial pathology in 30% of postmenopausal women with benign endometrial cells on Pap smear, including:
    • Endometrial polyps (20%)
    • Endometrial hyperplasia (6%)
    • Endometrial adenocarcinoma (4%) 3
  • The risk is higher in women over 50 years compared to those aged 40-50 years 4

Management Recommendations

For Premenopausal Women

  • No further evaluation is recommended for asymptomatic premenopausal women with benign endometrial cells on Pap smear 1
  • Consider endometrial assessment in premenopausal women with:
    • Unexplained vaginal bleeding
    • Conditions suggesting chronic anovulation 1

For Postmenopausal Women

  • Endometrial assessment is recommended for all postmenopausal women with benign endometrial cells on Pap smear, regardless of symptoms 1, 2
  • The recommended diagnostic pathway includes:
    1. Transvaginal ultrasound to measure endometrial thickness
      • A thickness ≤4 mm has a high negative predictive value for endometrial cancer 2, 5
      • If endometrial thickness is ≥5 mm, proceed to tissue sampling 2, 5
    2. Endometrial tissue sampling using Pipelle or Vabra devices (sensitivity 99.6% and 97.1% respectively) 1, 2
    3. If initial sampling is inadequate or inconclusive, consider hysteroscopy with directed biopsies 1, 5

Types of Endometrial Cells and Their Significance

  • Glandular cells carry greater risk than stromal cells/histiocytes 6
  • The presence of endometrial glandular cells in Pap smears was associated with five times the likelihood of significant endometrial disease compared to women with normal Pap smears 6
  • Degenerative endometrial debris accompanied by benign-looking endometrial cells may be particularly concerning, with one study finding malignancy in 41% of such cases regardless of menopausal status 7

Special Considerations

  • Hormone replacement therapy (HRT) increases the rate of shedding of benign-appearing endometrial cells but does not eliminate the elevated risk of pathology 1
  • Benign-appearing glandular cells after hysterectomy (derived from small accessory ducts, foci of benign adenosis, or prolapse of the fallopian tube) have no clinical significance 1

Potential Pitfalls

  • Do not dismiss the finding of normal endometrial cells in postmenopausal women as insignificant, even in asymptomatic patients 2
  • The false-negative rate of office endometrial biopsy is approximately 10%, requiring follow-up if clinical suspicion remains high 2, 5
  • Do not rely solely on Pap smears for evaluation of endometrial pathology, as they are designed primarily for cervical cancer screening 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Significance of Normal Endometrial Cells in Pap Smears After Menopause

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Abnormal Endometrial Thickness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.